They take a range of forms and are an increasingly common clinical issue with the growing list of cancers for which the immunologic agents are indicated.
Individuals at risk for atherosclerotic cardiovascular disease should have lipoprotein(a) levels tested to help guide primary and secondary prevention strategies, says the National Lipid Association.
Some imaginative applications have been proposed for this imaging technique that can reveal a patient s burden of potentially unstable coronary plaques, though it s still early days.